Report Categories
View AllRecent Articles
View All
PYXS Pyxis Oncology beats Q4 2025 loss estimates but shares shed 235 percent amid weak investor reaction
Why Busey BUSE earnings could be a turning point Q1 2026 EPS Exceeds Expectations
What Regeneron Pharmaceuticals REGN does that its rivals cannot replicate Q1 2026 Better Than Expected
NAMM Namib Minerals shares sink 49 as Q1 revenue slips 38 yearoveryear
Akebia AKBA Falls 1297 Watching 084 Support 20260519
CNBC Unveils 2026 Disruptor 50 List AI Now Central to Every Major Sector
Vine Hill VCIC Slips 654 Testing 1045 Support 20260515
Should You Sell Global GLP After 099 Drop 20260515
Weak Market Breadth Sidelines Nifty as Consolidation Persists
Fortune Brainstorm Tech 2026 Marks 25th Anniversary in Aspen
Indian Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products
A Family Dilemma Timing the CashOut of Inherited CDs During Hospice Care
Technical Assessment Signals Bullish IntermediateTerm Outlook
Waterfield Advisors Equities Head Advises Staggered Accumulation as Peak Macro Concerns Ease
Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain
CMTL Q1 2026 Earnings EPS Beats Estimates by Over 40 Despite Net Loss
VSCO Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response
Team Inc Q1 2026 Earnings Adjusted Loss of 276 Per Share Amid Operational Challenges
EGO Q1 2026 Earnings EPS Surges Past Estimates by 33 Amid Operational Gains
Brookfield Corporation BN Q1 2026 Earnings EPS Beats Estimates Amidst Modest Stock Pullback
Myers Industries MYE Bounces 132 Approaches Key Resistance Near 2339
The Hartford Insurance Group HIG Holds Steady Near Support as Bullish Momentum Fades
707 Cayman Holdings JEM Holds Steady at 150 Consolidation Phase Signals Caution
Kemper Corporation KMPR Hovers Near Resistance After Modest Gain
Medicus Pharma MDCX Rallies 49 as Shares Test Resistance Near 032